HER2 mutations involve genetic alterations, while HER2 expression refers to protein overexpression, both impacting NSCLC treatment strategies. Fam-trastuzumab deruxtecan-nxki and ado-trastuzumab ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results